Evaluating Clinical Pathways for Ovarian Cancer Treatment and Maintenance Therapy

Evaluating Clinical Pathways for Ovarian Cancer Treatment and Maintenance Therapy

imedex

8 months
409 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Earn CME credit for this activity: https://www.naccme.com/program/2018-802-03 This on-demand activity examines the implications of BRCA mutational status, BRCAness, synthetic lethality, and within-class differences in the mechanisms of action, efficacy and safety, and indications of available and emerging PARP inhibitors for optimal ovarian cancer pathway integration. © 2018 NACCME, an HMP Company
Up Next Autoplay
Impacting HCC Outcomes with Multimodal Therapy: The Importance of Interdisciplinary Management
Impacting HCC Outcomes with Multimodal Therapy: The Importance of Interdisciplinary Management
Category: Liver Cancer
3 Views
imedex 6 days
CAR-T: Management of Cytokine Release Syndrome and Neurotoxicity
CAR-T: Management of Cytokine Release Syndrome and Neurotoxicity
Category: Lymphoma
1,009 Views
imedex 4 months
Update: Relapsed/Refractory Follicular Lymphoma
Update: Relapsed/Refractory Follicular Lymphoma
Category: Lymphoma
387 Views
imedex 4 months
Follicular Lymphoma: Update on Upfront and Maintenance Therapy
Follicular Lymphoma: Update on Upfront and Maintenance Therapy
Category: Lymphoma
324 Views
imedex 4 months
CAR-T in Lymphoma
CAR-T in Lymphoma
Category: Lymphoma
240 Views
imedex 4 months
Peripheral T-Cell Lymphoma: What is New on the Horizon?
Peripheral T-Cell Lymphoma: What is New on the Horizon?
Category: Lymphoma
226 Views
imedex 4 months
AML Case: A 54-year-old woman is in remission but MRD+
AML Case: A 54-year-old woman is in remission but MRD+
Category: Acute Myelogenous Leukemia
114 Views
imedex 5 months
Update: New Drugs for AML
Update: New Drugs for AML
Category: Acute Myelogenous Leukemia
175 Views
imedex 5 months
R/R High Risk CLL: Personalized Management Based on Patient Characteristics and Cytogenetics
R/R High Risk CLL: Personalized Management Based on Patient Characteristics and Cytogenetics
Category: Chronic Lymphocytic Leukemia
163 Views
imedex 5 months
CLL: Sequencing Monotherapy vs. Combination Therapy
CLL: Sequencing Monotherapy vs. Combination Therapy
Category: Chronic Lymphocytic Leukemia
87 Views
imedex 5 months